Healthcare fraud costs states and the federal government billions of dollars each year, much of it involving prescription drugs. Common types of prescription fraud include billing 3rd parties, especially government entities, for (a) prescriptions filled but never picked up by patents, (b) prescriptions filled with drugs that have already been paid for but returned to the pharmacy for various reasons (c) expensive compounded pain creams for which there are no legitimate uses, (d) diabetic testing supplies obtained from non-approved suppliers, (e) prescriptions for which there is no evidence the pharmacy had sufficient inventory in stock to do so, (f) prescriptions where the product dispensed was different than the product billed for, and (g) prescriptions that were not medically necessary (i.e. unauthorized refills, controlled substances where “corresponding responsibility” was not met, items for which there is no legitimate medical use, etc.)
CLINIPHARM SERVICES, through its consultant-owner, Jack H. Raber, Pharm.D., has extensive experience working with the United States Department of Health and Human Services, the United States Department of Justice, commercial prescription drug benefit providers, and attorneys representing Qui tam relators (“whistleblowers”) in false claims and fraud investigations involving 3rd party pharmacy benefits. Dr. Raber also has extensive experience working with attorneys defending pharmacy providers accused of false claims and prescription fraud by 3rd party payers.
Services include, but are not limited to oversight and compliance audits of prescription drug benefit programs, litigation assistance and expert testimony in Qui tam actions against pharmacy providers, and litigation assistance and expert testimony when defending pharmacy providers against accusations of false claims and prescription fraud.